Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00843167 · ClinicalTrials.gov registry record · Phase 2
Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy
A Phase 2 study, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT00843167 is a Phase 2 study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 54 participants.
The verdict
NCT00843167, a Phase 2 study, has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
RATIONALE: Broccoli sprout extract supplements may slow the growth of tumor cells or abnormal cells and may be an effective treatment for ductal carcinoma in situ and/or atypical ductal hyperplasia. PURPOSE: This randomized phase II trial is studying how well broccoli sprout extract works in treating women with a diagnosis of breast cancer, ductal carcinoma in situ and/or atypical ductal hyperplasia.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT broccoli sprout extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00843167
The ClinicalTrials.gov registry entry for NCT00843167 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00843167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00843167 about?
NCT00843167 is a clinical study titled "Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy". RATIONALE: Broccoli sprout extract supplements may slow the growth of tumor cells or abnormal cells and may be an effective treatment for ductal carcinoma in situ and/or atypical ductal hyperplasia. PURPOSE: This randomized phase II trial is studying how well broccoli sprout extract works in treati...
What is the current status of trial NCT00843167?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2009-08. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00843167?
The interventions under investigation include: placebo (OTHER), broccoli sprout extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00843167?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.